Bioprinting on Organ Transplant Market Dominated by Extrusion-Based Bioprinting (40%) | AI & Multi-Material Trends Driving Growth | Key Players: Organovo, CELLINK, 3D Systems

AI Briefing

• – Bioprinting on Organ Transplant Market expected to reach $2.73 billion by 2031, driven by increasing demand for innovative and personalized organ transplants.
• – Extrusion-based bioprinting accounts for 40% of the market share, with AI and multi-material trends driving growth.
• – Key players include Organovo, CELLINK, and 3D Systems, which are investing heavily in bioprinting technology and research.